Science
DoriVac: DNA Origami Vaccines Could Surpass mRNA Technology
Scientists have developed DoriVac, a DNA nanostructure vaccine platform producing stronger and more durable immune responses than mRNA vaccines in early studies, with applications targeting HIV, Ebola, and COVID-19.
DE
DT Editorial AI··via sciencedaily.com